Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Uvagrandol
Cat. No.:
OB0425LY-324
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Uvagrandol has anti-inflammatory and antioxidant activities that inhibits α-glucosidase and porcine lipase.
Formula:
C21H22O7
Formula Weight:
386.4
Specification
Target:
Glucosidase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Uvagrandol can be used in the research of Type 2 diabetes and obesity.
